LINQ II Insertable Cardiac Monitor vs Steth IO
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose LINQ II if your patient requires long-term, continuous, and passive monitoring for infrequent or suspected arrhythmias over an extended period, up to 4.5 years. This tool is ideal for diagnosing elusive cardiac events without requiring active patient interaction for data collection, offering discreet and highly accurate AI-powered surveillance.
View LINQ II Insertable Cardiac Monitor →Choose Steth IO if…
Choose Steth IO if you need an active, on-demand diagnostic aid that transforms a smartphone into a powerful stethoscope for real-time auscultation, visualization, and sharing of heart and lung sounds. This tool is particularly well-suited for telemedicine, remote patient monitoring, or point-of-care scenarios where immediate, shareable physical exam data is critical for diagnosis and collaboration.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | Steth IO |
|---|---|---|
| Pricing | Unknown | Customized pricing; subscription-based for steth io spot. |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Steth IOSteth IO leverages familiar smartphone technology, transforming a mobile device into an interactive diagnostic aid for clinicians. Its real-time visualization, recording, and sharing features offer a direct and intuitive workflow for active diagnostic use. LINQ II's usability focuses more on passive patient monitoring and remote clinician management for long-term care.
Clinical Value
LINQ II Insertable Cardiac MonitorThe LINQ II Insertable Cardiac Monitor provides long-term, continuous heart rhythm monitoring for up to 4.5 years, utilizing advanced AI algorithms (AccuRhythmu2122 AI) for enhanced accuracy in diagnosing intermittent arrhythmias. This sustained, AI-powered detection offers significant clinical value for a challenging diagnostic problem. Steth IO offers real-time auscultation enhancement but for a more immediate, snapshot diagnostic need.
Pricing & Value
Steth IOSteth IO offers transparent, publicly disclosed pricing for its 'Spot' version, including a subscription model and a free trial period with device purchase, making it accessible for individual practitioners and smaller clinics. In contrast, LINQ II's pricing is enterprise-negotiated and not publicly disclosed, which is less transparent and flexible for smaller-scale adoption.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic, the company behind LINQ II, is a global medical device leader with a long history (founded 1949) and a proven track record of deploying solutions to large health systems, with over 1 million patients having received a Medtronic ICM worldwide. Its HIPAA compliance and hybrid deployment model further solidify its enterprise readiness. Steth IO's 'user responsible for compliance' statement regarding HIPAA could be a significant hurdle for large enterprise adoption.
Innovation
LINQ II Insertable Cardiac MonitorLINQ II demonstrates innovation through its advanced AI algorithms (AccuRhythmu2122 AI) for enhanced accuracy in an insertable cardiac monitor, including an innovative PVC detection algorithm and remote programming capabilities. This represents a significant advancement in the core diagnostic capabilities of an implantable device. While Steth IO's smartphone integration is innovative, LINQ II's AI-driven diagnostic refinement within an implantable device offers a deeper technological leap in its specific domain.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a large and established global medical device company, is known for its comprehensive support infrastructure, including extensive online resources, manuals, and dedicated technical and patient services. While Steth IO provides contact information for support, the scale and breadth of Medtronic's support network are typically far greater due to its size and global presence.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | Steth IO |
|---|---|---|
| Product Type/Primary Function | Insertable Cardiac Monitor for long-term, continuous heart rhythm monitoring | Smartphone Stethoscope for hearing, visualizing, recording, and sharing heart and lung sounds |
| Company | Medtronic | STRATOSCIENTIFIC |
| Key Diagnostic Capability | AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias, innovative PVC detection algorithm | Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram), digital filters for sound enhancement and ambient noise attenuation |
| Remote Capabilities | Remote programming capability, MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option | Telemedicine capabilities (live auscultation, video calls, scheduling), remote patient monitoring |
| Monitoring Duration | Up to 4.5 years of continuous monitoring | Not specified |
| Specialties | Cardiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Steth IO.